What is the Price/OCF ratio for Cartesian Therapeutics, Inc. (RNAC)?

The Price/OCF ratio for RNAC stock is N/A.

What is the estimated TTM average Price/OCF ratio for Cartesian Therapeutics, Inc. (RNAC)?

The estimated TTM average Price/OCF ratio for RNAC stock is 10.16.

Compare

Cartesian Therapeutics, Inc.(RNAC)

Biotechnology · Frederick, MD

$7.03-0.11 (-1.52%)

Delayed quote: Oct 6, 2026, 1:29 PM EDT

Compare

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T17:33:57.399Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:33:57.399Z.

Quote observation: 2026-10-06T17:29:58.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 206,601,894
TTM operating cash flow · period ending 2026-06-30: -76,073,000

FMP input reference: 82e50dad054807a2d9cfcf78e4a189ad4456f1f756e397ab71e696e9b4df84c5

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Price/OCF Ratio

RNAC Price/OCF Ratio Chart

N/A

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-09-30.

RNAC Price/OCF Ratio

RNAC Average Price/OCF Ratio Chart

RNAC Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

PRICE/OCF RATIO AVG TTM

10.16

PRICE/OCF RATIO AVG 3Y

N/A

PRICE/OCF RATIO AVG 5Y

N/A

PRICE/OCF RATIO AVG 10Y

N/A

PRICE/OCF RATIO AVG 15Y

N/A

PRICE/OCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

RNAC Competitors' Price/OCF Ratio

RNAC

Cartesian Therapeutics, Inc.

Current

Market Cap

$206.60M

Price/OCF Ratio

N/A

TTM Avg

10.16

3Y Avg

N/A

5Y Avg

N/A

TRDA

Entrada Therapeutics, Inc.

vs RNAC

Market Cap

$206.91M

Price/OCF Ratio

N/A

TTM Avg

4.01

3Y Avg

4.01

5Y Avg

4.01

ETRA

Electra Therapeutics Inc.

vs RNAC

Market Cap

$206.12M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDEX

Pro-Dex, Inc.

vs RNAC

Market Cap

$205.20M

Price/OCF Ratio

28.34

TTM Avg

26.60

3Y Avg

21.85

5Y Avg

26.58

SION

Sionna Therapeutics, Inc.

vs RNAC

Market Cap

$205.31M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALEC

Alector, Inc.

vs RNAC

Market Cap

$203.98M

Price/OCF Ratio

N/A

TTM Avg

3.18

3Y Avg

3.20

5Y Avg

4.43

CGEN

Compugen Ltd.

vs RNAC

Market Cap

$209.91M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRLD

Prelude Therapeutics Incorporated

vs RNAC

Market Cap

$211.22M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XGN

Exagen Inc.

vs RNAC

Market Cap

$200.35M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRZN

Surrozen, Inc.

vs RNAC

Market Cap

$197.18M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Cartesian Therapeutics, Inc. (RNAC)	$206.60M	N/A	10.16	N/A	N/A
Entrada Therapeutics, Inc. (TRDA)vs ›	$206.91M	N/A	4.01	4.01	4.01
Electra Therapeutics Inc. (ETRA)vs ›	$206.12M	N/A	N/A	N/A	N/A
Pro-Dex, Inc. (PDEX)vs ›	$205.20M	28.34	26.60	21.85	26.58
Sionna Therapeutics, Inc. (SION)vs ›	$205.31M	N/A	N/A	N/A	N/A
Alector, Inc. (ALEC)vs ›	$203.98M	N/A	3.18	3.20	4.43
Compugen Ltd. (CGEN)vs ›	$209.91M	N/A	N/A	N/A	N/A
Prelude Therapeutics Incorporated (PRLD)vs ›	$211.22M	N/A	N/A	N/A	N/A
Exagen Inc. (XGN)vs ›	$200.35M	N/A	N/A	N/A	N/A
Surrozen, Inc. (SRZN)vs ›	$197.18M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio FAQ

What is the Price/OCF ratio for Cartesian Therapeutics, Inc. (RNAC)?: The Price/OCF ratio for RNAC stock is N/A.
What is the estimated TTM average Price/OCF ratio for Cartesian Therapeutics, Inc. (RNAC)?: The estimated TTM average Price/OCF ratio for RNAC stock is 10.16.

RNAC Price/OCF Ratio History

DATE	PRICE/OCF RATIO
2021-09-30	10.45
2021-09-29	10.35
2021-09-28	10.87
2021-09-27	11.15
2021-09-24	10.85
2021-09-23	11.05
2021-09-22	11.25
2021-09-21	10.72
2021-09-20	10.47
2021-09-17	11.18
2021-09-16	10.47
2021-09-15	10.72
2021-09-14	10.07
2021-09-13	10.87
2021-09-10	11.07
2021-09-09	10.95
2021-09-08	10.95
2021-09-07	11.20
2021-09-03	11.25
2021-09-02	11.60
2021-09-01	10.92
2021-08-31	10.90
2021-08-30	10.82
2021-08-27	10.10
2021-08-26	10.05
2021-08-25	10.22
2021-08-24	10.15
2021-08-23	10.30
2021-08-20	9.89
2021-08-19	9.59
2021-08-18	9.79
2021-08-17	10.45
2021-08-16	10.27
2021-08-13	10.85
2021-08-12	10.97
2021-08-11	9.59
2021-08-10	9.89
2021-08-09	9.69
2021-08-06	9.72
2021-08-05	9.62
2021-08-04	9.07
2021-08-03	9.29
2021-08-02	8.89
2021-07-30	8.69
2021-07-29	9.02
2021-07-28	9.37
2021-07-27	8.66
2021-07-26	8.51
2021-07-23	8.69
2021-07-22	8.44
2021-07-21	9.62
2021-07-20	9.39
2021-07-19	9.17
2021-07-16	9.12
2021-07-15	9.07
2021-07-14	9.27
2021-07-13	9.67
2021-07-12	9.87
2021-07-09	10.02
2021-07-08	9.84
2021-07-07	9.79
2021-07-06	10.50
2021-07-02	10.70
2021-07-01	11.00
2021-06-30	11.20
2021-06-29	11.20
2021-06-28	11.95
2021-06-25	12.38
2021-06-24	12.46
2021-06-23	12.24
2021-06-22	12.19
2021-06-21	12.91
2021-06-18	12.59
2021-06-17	13.31
2021-06-16	13.10
2021-06-15	13.37
2021-06-14	13.42
2021-06-11	13.31
2021-06-10	13.29
2021-06-09	12.62
2021-06-08	12.62
2021-06-07	12.51
2021-06-04	11.95
2021-06-03	11.95
2021-06-02	12.03
2021-06-01	12.03
2021-05-28	11.63
2021-05-27	11.65
2021-05-26	10.98
2021-05-25	9.56
2021-05-24	9.22
2021-05-21	8.55
2021-05-20	8.49
2021-05-19	8.22
2021-05-18	8.36
2021-05-17	7.88
2021-05-14	7.98
2021-05-13	7.85
2021-05-12	8.04
2021-05-11	7.93
2021-05-10	7.55
2021-05-07	8.33
2021-05-06	7.98
2021-05-05	7.85
2021-05-04	8.14
2021-05-03	8.47
2021-04-30	8.04
2021-04-29	8.44
2021-04-28	10.42
2021-04-27	10.47
2021-04-26	10.64
2021-04-23	10.29
2021-04-22	10.47
2021-04-21	10.29
2021-04-20	9.81
2021-04-19	10.21
2021-04-16	10.37
2021-04-15	10.53
2021-04-14	10.66
2021-04-13	10.45
2021-04-12	10.18
2021-04-09	11.20
2021-04-08	11.47
2021-04-07	11.12
2021-04-06	11.57
2021-04-05	11.89
2021-04-01	12.14
2021-03-31	11.66
2021-03-30	10.33
2021-03-29	10.02
2021-03-26	10.77
2021-03-25	11.31
2021-03-24	11.16
2021-03-23	11.65
2021-03-22	12.05
2021-03-19	11.79
2021-03-18	11.31
2021-03-17	11.75
2021-03-16	11.72
2021-03-15	11.72
2021-03-12	11.00
2021-03-11	10.05
2021-03-10	10.05
2021-03-09	10.10
2021-03-08	9.53
2021-03-05	9.77
2021-03-04	9.82
2021-03-03	10.41
2021-03-02	10.87
2021-03-01	11.36
2021-02-26	10.87
2021-02-25	11.03
2021-02-24	10.67
2021-02-23	10.78
2021-02-22	12.06
2021-02-19	12.09
2021-02-18	12.27
2021-02-17	12.83
2021-02-16	12.06
2021-02-12	11.83
2021-02-11	11.88
2021-02-10	12.12
2021-02-09	12.52
2021-02-08	12.88
2021-02-05	13.06
2021-02-04	12.96
2021-02-03	12.81
2021-02-02	11.42
2021-02-01	10.82
2021-01-29	10.31
2021-01-28	10.64
2021-01-27	10.77
2021-01-26	10.98
2021-01-25	10.42
2021-01-22	8.86
2021-01-21	8.66
2021-01-20	8.86
2021-01-19	8.89
2021-01-15	9.15
2021-01-14	9.51
2021-01-13	8.63
2021-01-12	8.79
2021-01-11	8.40
2021-01-08	8.58
2021-01-07	8.37
2021-01-06	8.14
2021-01-05	7.52
2021-01-04	7.70
2020-12-31	9.09
2020-12-30	9.09
2020-12-29	9.18
2020-12-28	9.60
2020-12-24	9.81
2020-12-23	10.02
2020-12-22	9.81
2020-12-21	9.21
2020-12-18	9.00
2020-12-17	9.24
2020-12-16	8.76
2020-12-15	9.09
2020-12-14	9.45
2020-12-11	9.66
2020-12-10	10.11
2020-12-09	9.69
2020-12-08	9.84
2020-12-07	9.72
2020-12-04	9.63
2020-12-03	9.69
2020-12-02	10.22
2020-12-01	10.23
2020-11-30	10.08
2020-11-27	10.26
2020-11-25	9.81
2020-11-24	9.75
2020-11-23	9.57
2020-11-20	9.66
2020-11-19	9.60
2020-11-18	9.30
2020-11-17	9.66
2020-11-16	9.75
2020-11-13	9.81
2020-11-12	9.27
2020-11-11	9.00
2020-11-10	9.09
2020-11-09	9.15
2020-11-06	9.09
2020-11-05	9.72
2020-11-04	9.90
2020-11-03	9.42
2020-11-02	8.94
2020-10-30	8.88
2020-10-29	9.72
2020-10-28	10.08
2020-10-27	8.88
2020-10-26	9.39
2020-10-23	8.49
2020-10-22	8.07
2020-10-21	7.80
2020-10-20	6.54
2020-10-19	6.84
2020-10-16	7.47
2020-10-15	6.33
2020-10-14	6.24
2020-10-13	6.39
2020-10-12	6.12
2020-10-09	6.06
2020-10-08	5.79
2020-10-07	5.10
2020-10-06	4.92
2020-10-05	4.95
2020-10-02	5.01
2020-10-01	4.92

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.

Frederick, MD

75 employees

cartesiantherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Carsten Brunn

View full financials

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Cartesian Therapeutics, Inc. (RNAC)

$206.60M

N/A

10.16

N/A

Entrada Therapeutics, Inc. (TRDA)vs ›

$206.91M

N/A

4.01

Electra Therapeutics Inc. (ETRA)vs ›

$206.12M

N/A

Pro-Dex, Inc. (PDEX)vs ›

$205.20M

28.34

26.60

21.85

26.58

Sionna Therapeutics, Inc. (SION)vs ›

$205.31M

N/A

Alector, Inc. (ALEC)vs ›

$203.98M

N/A

3.18

3.20

4.43

Compugen Ltd. (CGEN)vs ›

$209.91M

N/A

Prelude Therapeutics Incorporated (PRLD)vs ›

$211.22M

N/A

Exagen Inc. (XGN)vs ›

$200.35M

N/A

Surrozen, Inc. (SRZN)vs ›

$197.18M

N/A

Price/OCF Ratio Formula & Definition

DATE

PRICE/OCF RATIO

2021-09-30

10.45

2021-09-29

10.35

2021-09-28

10.87

2021-09-27

11.15

2021-09-24

10.85

2021-09-23

11.05

2021-09-22

11.25

2021-09-21

10.72

2021-09-20

10.47

2021-09-17

11.18

2021-09-16

10.47

2021-09-15

10.72

2021-09-14

10.07

2021-09-13

10.87

2021-09-10

11.07

2021-09-09

10.95

2021-09-08

10.95

2021-09-07

11.20

2021-09-03

11.25

2021-09-02

11.60

2021-09-01

10.92

2021-08-31

10.90

2021-08-30

10.82

2021-08-27

10.10

2021-08-26

10.05

2021-08-25

10.22

2021-08-24

10.15

2021-08-23

10.30

2021-08-20

9.89

2021-08-19

9.59

2021-08-18

9.79

2021-08-17

10.45

2021-08-16

10.27

2021-08-13

10.85

2021-08-12

10.97

2021-08-11

9.59

2021-08-10

9.89

2021-08-09

9.69

2021-08-06

9.72

2021-08-05

9.62

2021-08-04

9.07

2021-08-03

9.29

2021-08-02

8.89

2021-07-30

8.69

2021-07-29

9.02

2021-07-28

9.37

2021-07-27

8.66

2021-07-26

8.51

2021-07-23

8.69

2021-07-22

8.44

2021-07-21

9.62

2021-07-20

9.39

2021-07-19

9.17

2021-07-16

9.12

2021-07-15

9.07

2021-07-14

9.27

2021-07-13

9.67

2021-07-12

9.87

2021-07-09

10.02

2021-07-08

9.84

2021-07-07

9.79

2021-07-06

10.50

2021-07-02

10.70

2021-07-01

11.00

2021-06-30

11.20

2021-06-29

11.20

2021-06-28

11.95

2021-06-25

12.38

2021-06-24

12.46

2021-06-23

12.24

2021-06-22

12.19

2021-06-21

12.91

2021-06-18

12.59

2021-06-17

13.31

2021-06-16

13.10

2021-06-15

13.37

2021-06-14

13.42

2021-06-11

13.31

2021-06-10

13.29

2021-06-09

12.62

2021-06-08

12.62

2021-06-07

12.51

2021-06-04

11.95

2021-06-03

11.95

2021-06-02

12.03

2021-06-01

12.03

2021-05-28

11.63

2021-05-27

11.65

2021-05-26

10.98

2021-05-25

9.56

2021-05-24

9.22

2021-05-21

8.55

2021-05-20

8.49

2021-05-19

8.22

2021-05-18

8.36

2021-05-17

7.88

2021-05-14

7.98

2021-05-13

7.85

2021-05-12

8.04

2021-05-11

7.93

2021-05-10

7.55

2021-05-07

8.33

2021-05-06

7.98

2021-05-05

7.85

2021-05-04

8.14

2021-05-03

8.47

2021-04-30

8.04

2021-04-29

8.44

2021-04-28

10.42

2021-04-27

10.47

2021-04-26

10.64

2021-04-23

10.29

2021-04-22

10.47

2021-04-21

10.29

2021-04-20

9.81

2021-04-19

10.21

2021-04-16

10.37

2021-04-15

10.53

2021-04-14

10.66

2021-04-13

10.45

2021-04-12

10.18

2021-04-09

11.20

2021-04-08

11.47

2021-04-07

11.12

2021-04-06

11.57

2021-04-05

11.89

2021-04-01

12.14

2021-03-31

11.66

2021-03-30

10.33

2021-03-29

10.02

2021-03-26

10.77

2021-03-25

11.31

2021-03-24

11.16

2021-03-23

11.65

2021-03-22

12.05

2021-03-19

11.79

2021-03-18

11.31

2021-03-17

11.75

2021-03-16

11.72

2021-03-15

11.72

2021-03-12

11.00

2021-03-11

10.05

2021-03-10

10.05

2021-03-09

10.10

2021-03-08

9.53

2021-03-05

9.77

2021-03-04

9.82

2021-03-03

10.41

2021-03-02

10.87

2021-03-01

11.36

2021-02-26

10.87

2021-02-25

11.03

2021-02-24

10.67

2021-02-23

10.78

2021-02-22

12.06

2021-02-19

12.09

2021-02-18

12.27

2021-02-17

12.83

2021-02-16

12.06

2021-02-12

11.83

2021-02-11

11.88

2021-02-10

12.12

2021-02-09

12.52

2021-02-08

12.88

2021-02-05

13.06

2021-02-04

12.96

2021-02-03

12.81

2021-02-02

11.42

2021-02-01

10.82

2021-01-29

10.31

2021-01-28

10.64

2021-01-27

10.77

2021-01-26

10.98

2021-01-25

10.42

2021-01-22

8.86

2021-01-21

8.66

2021-01-20

8.86

2021-01-19

8.89

2021-01-15

9.15

2021-01-14

9.51

2021-01-13

8.63

2021-01-12

8.79

2021-01-11

8.40

2021-01-08

8.58

2021-01-07

8.37

2021-01-06

8.14

2021-01-05

7.52

2021-01-04

7.70

2020-12-31

9.09

2020-12-30

9.09

2020-12-29

9.18

2020-12-28

9.60

2020-12-24

9.81

2020-12-23

10.02

2020-12-22

9.81

2020-12-21

9.21

2020-12-18

9.00

2020-12-17

9.24

2020-12-16

8.76

2020-12-15

9.09

2020-12-14

9.45

2020-12-11

9.66

2020-12-10

10.11

2020-12-09

9.69

2020-12-08

9.84

2020-12-07

9.72

2020-12-04

9.63

2020-12-03

9.69

2020-12-02

10.22

2020-12-01

10.23

2020-11-30

10.08

2020-11-27

10.26

2020-11-25

9.81

2020-11-24

9.75

2020-11-23

9.57

2020-11-20

9.66

2020-11-19

9.60

2020-11-18

9.30

2020-11-17

9.66

2020-11-16

9.75

2020-11-13

9.81

2020-11-12

9.27

2020-11-11

9.00

2020-11-10

9.09

2020-11-09

9.15

2020-11-06

9.09

2020-11-05

9.72

2020-11-04

9.90

2020-11-03

9.42

2020-11-02

8.94

2020-10-30

8.88

2020-10-29

9.72

2020-10-28

10.08

2020-10-27

8.88

2020-10-26

9.39

2020-10-23

8.49

2020-10-22

8.07

2020-10-21

7.80

2020-10-20

6.54

2020-10-19

6.84

2020-10-16

7.47

2020-10-15

6.33

2020-10-14

6.24

2020-10-13

6.39

2020-10-12

6.12

2020-10-09

6.06

2020-10-08

5.79

2020-10-07

5.10

2020-10-06

4.92

2020-10-05

4.95

2020-10-02

5.01

2020-10-01

4.92

Price/OCF Ratio: N/A

RNAC Price/OCF Ratio Chart

RNAC Average Price/OCF Ratio Chart

RNAC Price/OCF Ratio Metrics

RNAC Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Price/OCF Ratio FAQ

RNAC Price/OCF Ratio History

Related Metrics

Price/OCF Ratio: N/A

RNAC Price/OCF Ratio Chart

RNAC Average Price/OCF Ratio Chart

RNAC Price/OCF Ratio Metrics

RNAC Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Price/OCF Ratio FAQ

RNAC Price/OCF Ratio History

Related Metrics